Probiotics potentiate IL-6 production in IL-1β-treated Caco-2 cells through a heat shock-dependent mechanism

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 3, 2007, Pages

  Reilly, Natasha ^a   Poylin, Vitaliy ^a   Menconi, Michael ^a   Onderdonk, Andrew ^b   Bengmark, Stig ^c   Hasselgren, Per Olof ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cytokines; Inflammation; Intestine

Indexed keywords

HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROBIOTIC AGENT; QUERCETIN; SMALL INTERFERING RNA;

ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; INTESTINE EPITHELIUM CELL; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BLOTTING, WESTERN; CACO-2 CELLS; CELLS, CULTURED; ENTEROCYTES; ESCHERICHIA COLI; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LACTOBACILLUS; PROBIOTICS; QUERCETIN; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 34548409068     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00770.2006     Document Type: Article

References (53)

1. Annuk H, Shchepetova J, Kullisaar T, Songisepp E, Zilmer M, Mikelsaar M. Characterization of intestinal lactobacilli as putative probiotic candidates. J Appl Microbiol 94: 403-412, 2003.
2. Barton BE, Jackson JV. Protective role of interleukin-6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun 61: 1496-1499, 1993.
3. Bengmark S. Synbiotics and the mucosal barrier in critically ill patients. Curr Opin Gastroenterol 21: 712-716, 2005.
4. Bengmark S, Martindale R. Probiotics and synbiotics in clinical medicine. Nutr Clin Pract 20: 244-261, 2005.
5. Bibel DJ. Bacterial interference, bacteriotherapy, bacterioprophylaxis. In: Bacterial Interference, edited by Aly R and Shinefield M. Boca Raton, FL: CRC Press, 1982, p. 1-12.
6. Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remant E, Remon JP, van Deventer SJ, Neirynck S, Peppelenbosch MP, Steidler L. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 4: 754-759, 2006.
7. Bush KT, Goldberg AL, Nigam SK. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem 14: 9086-9092, 1997.
8. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, Poggioli G, Miglioli M, Campieri M. Prophylaxis of pouchitis onset with probiotic therapy: a doube-blind, placebo-controlled trial. Gastroenterology 124: 1202-1209, 2003.
9. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzochi G, Poggioloi G, Miglioli M, Campieri M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305-309, 2000.
10. Hasselgren PO. The significance of intestinal cytokines. In: Cytokines and the Abdominal Surgeon, edited by Schein M and Wise L. Austin, TX: Landes, Austin, 1998, p. 197-213.
11. Hershko DD, Robb BW, Luo GJ, Paxton JH, Hasselgren PO. Interleukin-6 induces thermotolerance in cultured Caco-2 cells independent of the heat shock response. Cytokine 21: 1-9, 2003.
12. Hungness ES, Robb BW, Luo GJ, Hershko DD, Hasselgren PO. Hyperthermia-induced heat shock activates the transcription factor C/EBPβ and augments IL-6 production in human intestinal epithelial cells. J Am Coll Surg 195: 619-626, 2002.
13. Isolauri E. Probiotics in human disease. Am J Clin Nutr 73: 1142S-1146S, 2001.
14. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88: 90-97, 1991.
15. Isolauri E, Kirjavainen PV, Salminen S. Probiotics: a role in the treatment of intestinal infection and inflammation. Gut 3: III54 -III59, 2002.
16. Kawazoe Y, Nakai A, Tanabe M, Nagata K. Proteasome inhibition leads to the activation of all members of the heat shock factor family. Eur J Biochem 255: 356-362, 1998.
17. Luyer MD, Buurman WA, Hadfoune M, Speelmans G, Knol J, Jacobs JA, Dejong CHC, Vriesema AJM, Greve JWM. Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun 73: 3686-3692, 2005.
18. Ma D, Forsythe P, Bienenstock J. Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 72: 5308-5314, 2004.
19. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, DeSimone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121: 580-591, 2001.
20. Mathew A, Mathur SK, Morimoto RI. Heat shock response and protein degradation: regulation of HSF 2 by the ubiquitin-proteasome pathway. Mol Cell Biol 18: 5091-5098, 1998.
21. Mester M, Tompkins RG, Gelfand JA, Dinarello CA, Burke JF, Clarke BD. Intestinal production of IL-1α during endotoxemia in the mouse. J Surg Res 54: 584-591, 1993.
22. 2. Arch Surg 129: 1290-1295, 1994.
23. Meyer TA, Wang J, Tiao G, Ogle CK, Fischer JE, Hasselgren PO. Sepsis and endotoxemia stimulate intestinal interleukin-6 production. Surgery 118: 336-342, 1995.
24. Moon MR, Parikh AA, Pritts TA, Kane C, Fischer JE, Salzman AL, Hasselgren PO. Interleukin-1β induces complement component C3 and IL-6 production at the basolateral and apical membranes in a human intestinal epithelial cell line. Shock 13: 374-378, 2000.
25. Nagai N, Nakai A, Nagata K. Quercetin suppresses heat shock response by downregulation of HSF 1. Biochem Biophys Res Commun 208: 1099-1105, 1995.
26. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL. Prokaryotic regulation of epithelial responses by inhibition of IkB-α ubiquitination. Science 289: 1560-1563, 2000.
27. Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13: 1143-1147, 2001.
28. Papanicolaou DA, Wilder RL, Monolapas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. NIH conference. Ann Intern Med 128: 127-137, 1998.
29. Parikh AA, Moon MR, Kane CD, Salzman AL, Fischer JE, Hasselgren PO. Interleukin-6 production in human intestinal epithelial cells increases in association with the heat shock response. J Surg Res 77: 40-44, 1998.
30. Parikh AA, Salzman AL, Fischer JE, Szabo C, Hasselgren PO. Interleukin-1β and interferon-γ regulate interleukin-6 expression in cultured human intestinal epithelial cells. Shock 8: 249-255, 1997.
31. Petrof EA, Kojima K, Ropeleski MJ, Musch MW, Tao Y, DeSimone C, Chang EB. Probiotics inhibit nuclear factor-κB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127: 1474-1487, 2004.
32. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokines in human septic shock: relation to multiple organ failure and mortality. Chest 103: 565-575, 1993.
33. Pinto M, Robine-Leon S, Appay MD, Kedinger M, Triadon N, Dussaulx E, Lacroix, B, Simon-Assmann, P, Haffen, K, Fogh, J, and Zweibaum, A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 47: 323-330, 1983.
34. Pritts TA, Hungness ES, Hershko DD, Robb BW, Sun X, Luo GJ, Fischer JE, Wong HR, Hasselgren PO. Proteasome inhibitors induce heat shock response and increase IL-6 expression in human intestinal epithelial cells. Am J Physiol Regul Integr Comp Physiol 282: R1016-R1026, 2002.
35. Pritts TA, Hungness E, Wang Q, Robb B, Hershko D, Hasselgren PO. Mucosal and enterocyte IL-6 production during sepsis and endotoxemia. Role of transcription factors and regulation by the stress response. Am J Surg 183: 372-383, 2002.
36. Rayers N, Seehofer D, Theruvath T, Langrehr JM, Muller AR, Bengmark S, Neuhaus P. Combined perioperative enteral supply of bioactive pre- and probiotics abolishes postoperative bacterial infections in human liver transplantation - a randomized, double-blind clinical trial. Am J Transplant 5: 125-130, 2005.
37. Reid G, Howard J, Gan BS. Can bacterial interference prevent infection? Trends Microbiol 9: 424-428, 2001.
38. Salminen S, Ouwehand A, Benno Y, Lee YK. Probiotics: how should they be defined? Trends Food Sci Technol 10: 107-110, 1999.
39. Savidge TC, Newman PG, Pan WH, Weng MQ, Shi HN, McCormick BA, Quaroni A, Walker WA. Lipopolysaccharide-induced human enterocyte tolerance to cytokine-mediated interleukin-8 production may occur independently of TLR-4/MD-2 signaling. Pediatr Res 59: 89-95, 2006.
40. Shanley TP, Foreback JL, Pemick DG, Ulich TR, Kunkel SL, Ward PA. Regulatory effects of interleukin-6 in immunoglobulin G immune-complex-induced lung injury. Am J Pathol 151: 193-203, 1997.
41. Sitaraman SV, Merlin D, Wang L, Wong M, Gewirtz AT, Si-Tahar M, Madara JL. Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest 107: 861-869, 2001.
42. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289: 1352-1355, 2000.
43. Tao Y, Drabik KA, Waypa TS, Musch MW, Alverdy JC, Schneewind O, Chang EB, Petrof EO. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 290: C1018-C1030, 2006.
44. Todoriki K, Mukai T, Sato S, Toba T. Inhibition of adhesion of food-borne pathogens to Caco-2 cells by Lactobacillus strains. J Appl Microbiol 91: 154-159, 2001.
45. Wang Q, Hasselgren PO. Heat shock response reduces intestinal permeability in septic mice: potential role of interleukin-10. Am J Physiol Regul Integr Comp Physiol 282: R669-R676, 2002.
46. Wang W, Smail N, Wang P, Chaudry IH. Increased gut permeability after hemorrhage is associated with upregualtion of local and systemic IL-6. J Surg Res 79: 39-46, 1998.
47. Wang Q, Sun X, Pritts TA, Wong HR, Hasselgren PO. Induction of the stress response increases interleukin-6 production in the intestinal mucosa of endotoxemic mice. Clin Sci 99: 489-496, 2000.
48. Wang Q, Wang JJ, Boyce S, Fischer JE, Hasselgren PO. Endotoxemia and IL-1β stimulate mucosal IL-6 production in different parts of the gastrointestinal tract. J Surg Res 76: 27-31, 1998.
49. Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee M, Enders C, Sonnenborn U, Nuding S, Bengmark S, Fellermann K, Schroder JM, Stange EF. NF-κB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 72: 5750-5758, 2004.
50. Wei W, Yang H, Cao P, Menconi M, Chamberlain C, Petkova V, Hasselgren PO. Degradation of C/EBP beta in cultured myotubes is calpain-dependent. J Cell Physiol 208: 386-398, 2006.
51. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK. IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101: 311-320, 1998.
52. Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277: 50959-50965, 2002.
53. Zhou M, Wu X, Ginsberg HN. Evidence that a rapidly turning over protein, normally degraded by proteasomes, regulates hsp72 gene transcription in HepG2 cells. J Biol Chem 271: 24769-24775, 1996.